Skip to Main Content

Paper Details

Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibition.
JCI Insight
10
2023
Author NameAffiliation
Michael E MarchCenter for Applied Genomics.
Arupa GangulyPerelman School of Medicine at the University of Pennsylvania
Ian D Krantz
Ian D Krantz
Lea F Surrey
Dong LiCenter for Applied Genomics.
Hakon HakonarsonCenter for Applied Genomics.
Hakon HakonarsonCenter for Applied Genomics.
  • 1 - 8

Datasets

Release 1.2